A
$ Value
$0
Shares
20,900
Price
$0
Filed
Jun 3
Insider
Name
Kosacz Barbara
Title
—
CIK
0001763316
Roles
Director
Transaction Details
Transaction Date
2025-05-30
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
20,900
Footnotes
The shares subject to the option will vest on the earlier of (i) May 30, 2026, or (ii) the day immediately before the date of the next annual meeting of the Issuer's stockholders that occurs after May 30, 2025. The option reported was granted pursuant to the terms of the Issuer's Outside Director Compensation Policy.
Filing Info
Kosacz Barbara's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-09 | LONA | A | $0 |
| 2025-05-30 | ATHA | A | $0 |
| 2025-05-21 | XOMA | A | $0 |
| 2025-05-21 | XOMA | A | $0 |
Other Insiders at ATHA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| EDELMAN JOSEPH | — | — | 2026-04-09 |
| FLUKE JOHN M JR | — | — | 2026-04-09 |
| JOHNSON JAMES A | — | — | 2026-04-09 |
| PICKERING GRANT | — | — | 2026-04-09 |
|
Litton Mark James
PRESIDENT and CEO
|
— | $28K | 2026-04-09 |
| Panzara Michael A. | — | — | 2026-04-09 |
| Romano Kelly A | — | — | 2026-04-09 |
| Kosacz Barbara | — | — | 2026-04-09 |
|
San Martin Javier
CHIEF MEDICAL OFFICER
|
— | $9K | 2026-04-09 |
|
CHURCH KEVIN
CHIEF SCIENTIFIC OFFICER
|
— | $7K | 2026-04-09 |
|
Worthington Mark
GENERAL COUNSEL and CCO
|
— | $7K | 2026-04-09 |
|
Renninger Robert
CHIEF FINANCIAL OFFICER
|
— | $5K | 2026-04-09 |